9. Chen Z, et al. Is HER2 ultra‑low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients. Breast Cancer Res Treat. 2023 Nov;202(2):313-323. 10. National Comprehensive Cance...
9.Chen Z, et al. Is HER2 ultra‑low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients. Breast Cancer Res Treat. 2023 Nov;202(2):313-323. 10.National Comprehensive Cancer Network®. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines...
化疗既往是HR阳性/HER2低表达晚期乳腺癌重要的治疗手段,也是CDK4/6抑制剂进展后但对化疗耐受性较好的患者不容忽视的选择。2024年V2版美国国立综合癌症网络(NCCN)指南指出[5],及时转换化疗是内脏危象或内分泌难治性乳腺癌这一人群的可...
From pivotal Phase III trials to novel therapeutic approaches, the ESMO 2024 conference will showcase groundbreaking data across various settings, including early and advanced/metastatic breast cancer.
乳腺癌(Breast cancer)(下) 5 治疗 5.1 方法注意事项 手术被认为是早期乳腺癌的主要治疗方法;许多患者通过单纯手术治愈。乳腺癌手术的目的包括完整切除原发肿瘤、切缘阴性以降低局部复发的风险、肿瘤及腋窝淋巴结(ALNs)病理分期以提供必要的预后信息。乳腺癌辅助治疗用于治疗微转移病灶(如逃出乳腺和区域淋巴结但还没...
So far, an individualised breast cancer follow-up care concept is lacking in Germany, although required by current clinical guidelines [15]. Within the framework of the German guideline of diagnosis and care of breast cancer (“AWMF S3 Leitlinie”) and the development of Cancer Survivorship ...
6.National ComprehensiveCancer Network®. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Breast cancer. Version 2.2024-March 11,2024. 7.https://www.esmo.org/living-guidelines/esmo-metastatic-breast-cancer-living-guideline ...
7.National Comprehensive Cancer Network. Breast Cancer (Version 6.2024). Available at: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1419 声明:本材料由阿斯利康支持,仅供医药卫生专业人士参考 审批编号:CN-147056 过期时间:2025-11-17 -THE END- 医脉通是专业的在线医生平台,“感知世界...
NCCN Updates Guidelines on Breast Cancer TreatmentChristin Melton
National Comprehensive Cancer Network (NCCN) United States Preventive Services Task Force (USPSTF) For further information, see Breast Cancer and Breast Cancer Guidelines. Next: Guidelines What to Read Next on Medscape Related Conditions and Diseases Breast Cancer Patient Simulation: A 63-Year-...